Correlation Between Virtus Investment and BioNTech

Can any of the company-specific risk be diversified away by investing in both Virtus Investment and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virtus Investment and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virtus Investment Partners, and BioNTech SE, you can compare the effects of market volatilities on Virtus Investment and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virtus Investment with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virtus Investment and BioNTech.

Diversification Opportunities for Virtus Investment and BioNTech

0.48

Correlation Coefficient

Virtus Investment  BioNTech

Very weak diversification

The 3 months correlation between Virtus and BioNTech is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Virtus Investment Partners, and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Virtus Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virtus Investment Partners, are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Virtus Investment i.e., Virtus Investment and BioNTech go up and down completely randomly.

Pair Corralation between Virtus Investment and BioNTech

Given the investment horizon of 90 days Virtus Investment Partners, is expected to under-perform the BioNTech. But the stock apears to be less risky and, when comparing its historical volatility, Virtus Investment Partners, is 1.85 times less risky than BioNTech. The stock trades about -0.21 of its potential returns per unit of risk. The BioNTech SE is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  11,351  in BioNTech SE on December 22, 2024 and sell it today you would lose (1,813) from holding BioNTech SE or give up 15.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Virtus Investment Partners,  vs.  BioNTech SE

Virtus Investment

Risk-Adjusted Performance

Very Weak

Over the last 90 days Virtus Investment Partners, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

BioNTech SE

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Virtus Investment and BioNTech

The main advantage of trading using opposite Virtus Investment and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virtus Investment position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Virtus Investment Partners, and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.